1-7 of 7
Nathaniel Rosko, PharmD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abnormal Metaphase Cytogenetics Adds to Currently Known Risk-Factors for Venous Thromboembolism in Multiple Myeloma: Derivation of the PRISM score

Rajshekhar Chakraborty, MD, Lisa Rybicki, MS, Jason Valent, MD, Alex V. Mejia Garcia, MD, Beth M. Faiman, PhDCNP, Jack Khouri, MD, Nathaniel Rosko, PharmD, Christy J. Samaras, DO, Matt Kalaycio, MD, Faiz Anwer, MD, Alok A Khorana, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-137525
Published: 2020
Journal Articles

Rapid Infusion Daratumumab Is Safe in Patients with AL Amyloidosis

Nathaniel Rosko, PharmD, Hanjie Mo, PharmD, Joslyn Rudoni, PharmD, Caitlin Siebenaller, PharmD, Sarah S Lee, MD, Rajshekar Chakraborty, MD, Beth M. Faiman, PhDCNP, Jack Khouri, MD, Alex V. Mejia Garcia, MD, Christy J. Samaras, DO, Faiz Anwer, MD, Jason Valent, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1838.
https://doi.org/10.1182/blood-2019-124775
Published: 2019
Journal Articles

Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma

Rajshekar Chakraborty, MD, Lisa Rybicki, MS, Megan Nakashima, MD, Robert M. Dean, MD, Beth M. Faiman, PhDCNP, Christy J. Samaras, DO, Nathaniel Rosko, PharmD, Jason Valent, MD, Faiz Anwer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4359.
https://doi.org/10.1182/blood-2019-123861
Published: 2019
Journal Articles

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

Diana Basali, MD, Rajshekhar Chakraborty, MD, Lisa Rybicki, MS, Nathaniel Rosko, PharmD, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Hayley Dysert, Beth M. Faiman, PhDCNP, Kimberly Hamilton, APRN/PA, Matt Kalaycio, MD, Jason Valent, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5566.
https://doi.org/10.1182/blood-2019-129002
Published: 2019
Journal Articles

External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients

Fahrettin Covut, MD, Ramsha Ahmed, MD, Christy J. Samaras, DO, Faiz Anwer, MD, Alex V. Mejia Garcia, MD, Dana E Angelini, MD, Beth M. Faiman, PhDCNP, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Saveta Mathur, CNP, Kimberly Hamilton, APRN/PA, Nathaniel Rosko, PharmD, Jason Valent, MD, Jack Khouri, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3148.
https://doi.org/10.1182/blood-2019-131400
Published: 2019
Journal Articles

Cost and Value Analysis of Standard Versus Rapid Daratumumab Infusion in Multiple Myeloma

Sarah S Lee, MD, Nathaniel Rosko, PharmD, Pramod Pinnamaneni, MD, Craig Savage, Alex V. Mejia Garcia, MD, Christy J. Samaras, DO, Jason Valent, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4802.
https://doi.org/10.1182/blood-2018-99-120291
Published: 2018
Journal Articles

Rapid Hematologic and Organ Responses with Daratumumab, Bortezomib and Dexamethasone in Patients with Relapsed/Refractory AL Amyloidosis

Sarah S Lee, MD, Nathaniel Rosko, PharmD, Bhumika J. Patel, MD, Madeline Waldron, PharmD, Jackie Tomer, MPH, Roman Goldman, CNP, Mary Ann Karam, RN, Janice Reed, RN, Beth M. Faiman, PhDCNP, Kimberly Hamilton, APRN/PA, Saveta Mathur, CNP, Christy J. Samaras, DO, Jason Valent, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2009.
https://doi.org/10.1182/blood-2018-99-119979
Published: 2018